Agranulocytosis during use of aprindine
Van Leeuwen, R.
Nederlands Tijdschrift Voor Geneeskunde 120(36): 1549-1550
1976
ISSN/ISBN: 0028-2162 PMID: 967294 Document Number: 101015
Document emailed within 1 workday
Related Documents
García Saavedra, V.; Peró Silva, A.; Llorente, A.; Richart, C. 1989: Fatal agranulocytosis induced by aprindine Revista Clinica Espanola 185(3): 169Brutsaert, D.L. 1974: Effects of aprindine on myocardial contractility Acta Cardiologica Suppl 18: 91-99
Oda, H.; Doutsu, Y.; Hiratani, K.; Miyazaki, T.; Komori, K.; Hayashi, T.; Kohno, S.; Yamaguchi, K.; Hirota, M.; Hara, K. 1990: A case of aprindine-induced pneumonitis Nihon Kyobu Shikkan Gakkai Zasshi 28(1): 183-188
Wirth, K.E.; Breithardt, G.; Michaelis, L. 1983: Detection of aprindine and its metabolites in plasma and urine Herz 8(5): 302-308
Petit-Guinovart, M.; Ballesta-Barcons, F. 1974: Effects of aprindine in disorders of the auriculoventricular conduction Acta Cardiologica Suppl 18: 369-387
Besse, P.; Choussat, A. 1974: Effects of aprindine (AC 1802) on myocardial function in man Acta Cardiologica Suppl 18: 217-231
Niederberger, M.; Gasic, S.; Haber, P. 1975: Effect of aprindine on extrasystole and hemodynamics in an exertion study Zeitschrift für Kardiologie Suppl 2: 85
Breithardt, G.; Gleichmann, U.; Seipel, L. 1973: Oral antiarrhythmic longtime therapy with aprindine (AC 1802) Verhandlungen der Deutschen Gesellschaft für Innere Medizin 79: 1001-1003
Kesteloot, H. 1974: General aspects of anti-arrhythmic treatment with aprindine Acta Cardiologica Suppl 18: 303-316
Misztal, G.; Przyborowski, L. 1995: Determination of aprindine in human plasma using reversed phase HPLC Die Pharmazie 50(3): 187-188
Kobayashi, K.; Itoh, S.; Fukuzaki, H. 1985: Anti-arrhythmia agents (II): Mexiletine, aprindine, tocainide and amiodarone Nihon Rinsho. Japanese Journal of Clinical Medicine 43(11): 2428-2434
Van Durme, J.P.; Rosseel, T.; Bogaert, M. 1974: Therapeutic effectiveness and plasma levels of a new antidysrhythmic drug: aprindine Acta Cardiologica Suppl 18: 233-234
Gerin, M.; Gerin, Y.; Duvernay, G.; Georges, A. 1974: Effects of aprindine (AC 1802) on cardiac function in conscious dogs Acta Cardiologica Suppl 18: 143-162
Carmeliet, E.; Verdonck, F. 1974: Effects of aprindine and lidocaine on transmembrane potentials and radioactive K efflux in different cardiac tissues Acta Cardiologica Suppl 18: 73-90
Iwasaki, S.; Araki, H.; Yamakawa, T.; Nishi, K.; Miyauchi, Y. 1989: Effects of aprindine and disopyramide on reperfusion-induced arrhythmias and cardiac function in isolated rat hearts Archives Internationales de Pharmacodynamie et de Therapie 300: 174-185
Pantlen, H.; Runge, M.; Luckmann, E. 1980: Effect of aprindine in patients with normal and pre-damaged impulse forming and excitation conducting system/First communication; Sinus node function Arzneimittel-Forschung 30(1): 92-95
Shimada, R.; Araki, H.; Orita, Y.; Nakagaki, O.; Nakamura, M. 1983: Cardiac effects of aprindine in patients with or without cardiac dysfunction: echocardiographic and clinical evaluation Clinical Therapeutics 5(4): 348-356
Coelho, E.; Bernik, V. 1973: Agranulocytosis Revista Paulista de Medicina 81(2): 128
Okubo, A. 1970: Agranulocytosis Nihon Rinsho. Japanese Journal of Clinical Medicine 28(Suppl): 1006-1007
Dev, V.J.; Rosenberg, T.; Krupp, P. 1994: Agranulocytosis and clozapine Bmj 309(6946): 54